| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |